All Episodes

Matthew Rabinowitz: Engineering a New Era of Diagnosis

Jurgi Camblong: Data-Driven Doctors Without Borders

Molly Gibson: Superintelligence and the Future of Drug Development

Mike Curtis: Pig Organs as a Bridge to Human Transplants

Markus Warmuth: Eliminating Pathogenic Proteins with Molecular Glue Degraders

Alicia Zhou: The Dark Matter for Cancer Immunotherapy Translation

Brad Ringeisen: CRISPR for Disease Elimination and Humanitarian Solutions

Zachary Roberts: Building a Viable Off-the-Shelf CAR T

Boyang Wang: Organ Swaps and Mass Preventative Gene Therapy to Extend Lifespan

Year In Review: My Personal Genomics Journey Redux

David Fischel: Surgical Robotics for Superhuman and Remote Operations

Katherine Stueland: The Diagnostic Odyssey Era Ends with Early Genomics

Rahul Gupta: Can Biotech Fix U.S. Healthcare Faster than Policy?

Michael Langer: Biotech Investing in the Data Age

Vanessa Almendro-Navarro: Baby KJ and The Promise of Custom Gene Editing

Shana Kelley: Instrumented Tissues for Monitoring Human Body In Real-Time

Mara Aspinall: Taking Diagnostics From Pitch to Patient

David Liu: Performing Chemistry on DNA to Unlock Personalized Gene Editing

Janice Chen: Unleashing CRISPR’s Clinical and Diagnostic Potential

Amber Salzman: Epigenetic Editing Aims to Refine Personalized Genetic Medicine

Mike Previte: Predicting Biology with Spatiotemporal Multiomics

Hervé Affagard: Creating Microbiomes to Fight Cancer, ALS, and More

Michelle Werner: Engineered tRNAs Offer Universal Solutions to Stop Codon Diseases

Cassie Hajek: Population Genomic Screens Need More Than Pathogenic Variants

Patrick Hsu, Serge Saxonov, and Gilad Almogy: Creating the Virtual Cell

Kate Sasser: How Lab-in-the-loop Turns Patient Data Into Patient Care

Kian Sadeghi: Is Personalized Genomics Undergoing a Direct-to-Consumer Renaissance?

Carlos D. Bustamante: Latin American Diversity’s Genetic Potential

Josh Denny: The Future of Precision Public Health

Uli Stilz: Conquering Complex Diseases Affecting Billions with Precision Medicine

Tomasz (Tom) Beer: Detecting Cancer Before Symptoms? MCED Leads the Way

Katy Rezvani: Allogeneic NK Cells Are Coming to Beat Cancer at a Clinic Near You

Toby Ferguson: From Bloodstream to Brain: Accessing the Neurogenetic Medicine Revolution

Tomi Pastinen: Treating All the Not-So-Rare “Rare Disease” Patients at Major Care Centers

Tom Whitehead: Not All Precision Medicine Heroes Wear Lab Coats

Harry Clifford: Carrying Medicine Into the Post-Moore’s Law Era

Michael Severino: Towards In Vivo Genome Editing of Humans

Jane Gibson: AMP and Molecular Diagnostics’ Existential Crisis

Helen Sabzevari: How to Turn $1,000,000 CAR Ts into “Real” Precision Medicines

Luca Quagliata: Weaving Genomic Profiling into Personalized Cancer Care

Geoff Oxnard: The Tipping Point for Adopting Precision Medicine